Marketing, Product Differentiation and Competition in the Market for Antiulcer Drugs
Charles King III
Greylock McKinnon Associates; Pleiades Consulting Group, Inc.
September 16, 2002
HBS Working Paper No. 01-014
This paper investigates one of the largest pharmaceutical markets using a discrete choice model that allows marketing to affect product differentiation. Four main results emerge from an analysis of monthly panel data on antiulcer drugs from 1977 to 1993. Observed drug characteristics became less important relative to marketing in determining demand. Total marketing by all firms reduced product differentiation and raised the cost of entry significantly. Although increasingly rivalrous, marketing expanded the market, increasing social welfare. Finally, estimated returns to eliminating one adverse drug interaction in the pioneer drug approximately equal its first two years of sales.
Number of Pages in PDF File: 49
Keywords: Advertising, marketing, discrete choice, pharmaceutical market, product differentiation, simulation
JEL Classification: D12, L65, I11, M31, M37, C25working papers series
Date posted: March 23, 2006
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo1 in 0.484 seconds